Alliancebernstein L.P. boosted its position in shares of Waystar Holding Corp. (NASDAQ:WAY – Free Report) by 4.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,415,442 shares of the company’s stock after acquiring an additional 146,510 shares during the quarter. Alliancebernstein L.P. owned 1.79% of Waystar worth $129,514,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in the company. Royal Bank of Canada grew its position in shares of Waystar by 11.3% in the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock valued at $808,000 after acquiring an additional 2,195 shares during the period. AQR Capital Management LLC bought a new stake in shares of Waystar in the 1st quarter valued at about $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Waystar by 91.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock worth $1,753,000 after purchasing an additional 22,364 shares during the period. NewEdge Advisors LLC acquired a new position in Waystar during the first quarter worth approximately $234,000. Finally, Goldman Sachs Group Inc. increased its position in Waystar by 13.4% during the first quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock worth $27,918,000 after buying an additional 88,256 shares during the last quarter.
Waystar Stock Performance
Shares of NASDAQ WAY opened at $24.61 on Tuesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.41 and a quick ratio of 1.41. The firm has a market cap of $4.72 billion, a price-to-earnings ratio of 40.34, a P/E/G ratio of 0.94 and a beta of 0.80. The stock’s fifty day moving average price is $26.83 and its two-hundred day moving average price is $32.84. Waystar Holding Corp. has a one year low of $21.13 and a one year high of $42.55.
Insiders Place Their Bets
In other Waystar news, insider Eric L. (Ric) Sinclair III sold 40,225 shares of the business’s stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $30.08, for a total value of $1,209,968.00. Following the completion of the sale, the insider owned 474,826 shares of the company’s stock, valued at $14,282,766.08. The trade was a 7.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 4.10% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on WAY shares. Freedom Capital raised Waystar from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 18th. Wall Street Zen cut Waystar from a “buy” rating to a “hold” rating in a research note on Saturday, February 21st. UBS Group began coverage on Waystar in a report on Monday, December 15th. They set a “buy” rating and a $41.00 price target for the company. BMO Capital Markets decreased their price objective on shares of Waystar from $47.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, February 18th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $41.00 price objective on shares of Waystar in a research report on Wednesday, February 18th. Three analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $37.06.
Get Our Latest Report on Waystar
About Waystar
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Featured Articles
- Five stocks we like better than Waystar
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
